Protective Effects of Quercetin on Anxiety-Like Symptoms and Neuroinflammation Induced by Lipopolysaccharide in Rats

• Published in: Evidence-based complementary and alternative medicine Vol. 2020; no. 2020; pp. 1 - 10
• Main Authors: Lee, Hyejung, Shim, Insop, Yeom, Mijung, Lee, Bombi, Hahm, Dae-Hyun
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 2020; Hindawi; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Anxiety; Behavior; Bioflavonoids; Brain-derived neurotrophic factor; Cyclooxygenase-2; Cytokines; Flavones; Flavonoids; IL-1β; Inflammation; Interleukin 6; Interleukins; Lipopolysaccharides; Mental disorders; mRNA; Neurobiology; Neuroprotection; Nitric oxide; Nitric-oxide synthase; Nonsteroidal anti-inflammatory drugs; Open-field behavior; Quercetin; RNA; Tumor necrosis factor-TNF; Variance analysis; Ventricle; Ventricles (cerebral); United States > US
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2020/4892415

Recently, neuroinflammation is thought to be one of the important causes of many neuropsychiatric diseases. Quercetin (QUER) is a natural flavonoid, and it is well known that QUER has antioxidative, anti-inflammatory, and neuroprotective effects. In our study, lipopolysaccharide (LPS) was injected into the lateral ventricle of rats to induce anxiety-like behaviors and neuroinflammation, and it was confirmed that chronic administration of QUER could improve anxiety-like symptoms. We also investigated the effects of QUER on inflammatory markers and its major mechanisms associated with inflammation in the hippocampus. Daily administration of QUER (10, 50, and 100 mg/kg) daily for 21 days significantly improved anxiety-like behaviors in the elevated plus-maze test and open field test. QUER administration significantly reduced inflammatory markers such as interleukin-6, interleukin-1β, cyclooxygenase-2, and nuclear factor-kappaB levels in the brain. In addition, QUER significantly increased the brain-derived neurotrophic factor (BDNF) mRNA level and decreased the nitric oxide synthase (iNOS) mRNA level. Therefore, our results have shown that QUER can improve anxiety-like behaviors caused by chronic neuroinflammation. This anxiolytic effect of QUER has been shown to be due to its anti-inflammatory effects and appropriate regulation of BDNF and iNOS expression. Thus, QUER provides the potential as a therapeutic agent to inhibit anxiety-like symptoms in neuropsychiatric diseases, such as anxiety.